Publications Details for:
Development and Application of a Bioluminescent Yeast-Reporter System for Screening Chemicals for Estrogenic and Androgenic Effects
Grant Number R831302
RFA: Development of High-Throughput Screening Approaches for Prioritizing Chemicals for the Endocrine Disruptors Screening Program (2003)
- Other
views:
Reference Type | Citation | Progress Report Year | Document Sources |
---|---|---|---|
Journal Article | Eldridge ML, Sanseverino J, Layton AC, Easter JP, Schultz TW, Sayler GS. Saccharomyces cerevisiae BLYAS, a new bioluminescent bioreporter for detection of androgenic compounds. Applied and Environmental Microbiology 2007;73(19):6012-6018. |
R831302 (Final) |
|
Journal Article | Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. British Medical Journal 2003;327(7425):1219-1221 |
R831302 (Final) |
not available |
Journal Article | Sanseverino J, Gupta RK, Layton AC, Patterson SS, Ripp SA, Saidak L, Simpson ML, Schultz TW, Sayler GS. Use of Saccharomyces cerevisiae BLYES expressing bacterial bioluminescence for rapid, sensitive detection of estrogenic compounds. Applied and Environmental Microbiology 2005;71(8):4455-4460. |
R831302 (2004) R831302 (2005) R831302 (2006) R831302 (Final) |
|
Presentation | Eldridge ML, Sanseverino J, Layton AC, Easter J, Schultz TW, Sayler GS. Development and application of a bioluminescent yeast-reporter system for screening chemicals for estrogenic and androgenic effects. Presented at the U.S. EPA, Office of Research and Development, Computational Toxicology Research Program Review, Research Triangle Park, NC, June 19-20, 2006. |
R831302 (2006) R831302 (Final) |
not available |
Presentation | Eldridge ML, Sanseverino J, Layton A, Easter J, Schultz TW, Sayler GS. A new bioluminescent S. cerevisiae bioreporter capable of rapid and sensitive detection of androgenic chemicals, suitable for high throughput applications. Presented at the 107th General Meeting of the American Society for Microbiology, Toronto, Ontario, Canada, May 21-25, 2007. |
R831302 (Final) |
not available |
Presentation | Sanseverino J, Layton AC, Saidak L, Easter J, Garrett V, Schultz TW, Sayler GS. A bioluminescent yeast-reporter system for screening chemicals for estrogenic effects. Presented at the EPA Science Forum, Washington, DC, June 1-3, 2004 (invited). |
R831302 (2004) R831302 (2005) R831302 (2006) R831302 (Final) |
not available |
Presentation | Sanseverino J. Bioluminescent sensing in eukaryotes. Presented at the Tennessee Mouse Genome Consortium, Fall Creek Falls, TN, November 18-20, 2004 (invited). |
R831302 (Final) |
not available |
Presentation | Sanseverino J. Bioluminescent reporter technology for the detection of endocrine-disrupting compounds. Presented at the STAR Computational Toxicology Progress Review Workshop, Research Triangle Park, July 18-19, 2005 (invited). |
R831302 (2005) R831302 (2006) R831302 (Final) |
not available |
Presentation | Sanseverino J, Layton AC, Easter JP, Saidak L, Garrett V, Schultz TW, Sayler GS. A bioluminescent estrogen yeast reporter system for determining estrogenic activity. Presented at the 105th General Meeting of the American Society for Microbiology, Atlanta, GA, June 5-9, 2005. |
R831302 (2005) R831302 (2006) R831302 (Final) |
not available |
Presentation | Sanseverino J, Layton A, Eldridge M, Yarbrough J, Schultz TW, Sayler GS. Development and application of a bioluminescent yeast-reporter system for screening chemicals for estrogenic and androgenic effects. Presented at the U.S. EPA, Office of Research and Development, Safe Pesticides/Safe Products (SP2) Program Review, Research Triangle Park, NC, February 7-9, 2007. |
R831302 (Final) R833376 (Final) |
not available |
Proceedings | Sanseverino J, Layton AC, Easter JP, Menn F-M, Saidak L, Garrett V, Schultz TW, Sayler GS. Application of a bioluminescent estrogen yeast-reporter system for determining the estrogenic activity in water and sediment samples at a superfund site. In: Proceedings of the National Ground Water Association Pharmaceuticals and Endocrine Disruptors Conference, Minneapolis, Minnesota, October 13-15, 2004. |
R831302 (2004) R831302 (2005) R831302 (2006) R831302 (Final) |
not available |